A RIKEN-developed mouse model of an enigmatic lung disease promises to unlock new biological insights and catalyze the development of treatments for millions affected globally. The research is ...
Their research demonstrated that a one-time treatment with their nanoparticles resulted in durable gene editing in mouse lungs for nearly two years. Further, their technique showed promise in ...
Alveolus created in vitro and in vivo models of chronic lung disease to test the candidate, which was also assessed in germ-free and humanized mouse models. The assessments suggest inhaled AB1000 ...